Cancer survival in Korea 1993-2002: A population-based study
Cancer survival in Korea 1993-2002: A population-based study
复制标题
DOI：
10.3346/jkms.2007.22.s.s5
复制
发表时间：
2007-09-01
影响因子：
4.5
通讯作者：
Shin, Hai-Rim
中科院分区：
文献类型：
--
作者：
Jung, Kyu-Won;Yim, Seorl;Shin, Hai-Rim
基于人群的存活率反映了具有各种自然病史和治疗模式的未选定患者的平均预后，也有助于评估特定区域癌症导向保健服务的效力和效率。虽然生存数据是根据医院数据报告的，但在韩国，基于人口登记的生存数据很少报告。基于韩国国家癌症发病率数据库，我们报告了1993-2002年间确诊的癌症患者的生存分析结果，并对其进行了跟踪调查，直至2005年12月31日。5年相对生存率(RSR)采用Ederer II法计算。采用Kaplan-Meier方法估计中位生存期和95%可信区间。在男性中，所有癌症的五年RSR在1993-1997年间为32.5%，在1998-2002年期间为37.8%。在女性中，所有癌症的五年RSR在1998年期间为53.7%，在19931997-2002年期间为57.0%。男性的前列腺癌和女性的乳腺癌和胃癌的存活率改善最大。中位生存期男性为16.3个月，女性为81.6个月。这一结果将有助于评估韩国的癌症治疗结果。
Population-based survival reflect the average prognosis of unselected patients with a variety of natural histories as well as treatment patterns and are also useful for evaluating effectiveness and efficiency of cancer-directed health services in a given region. Although survival data have been reported based on hospital data, the survival data from population-based registry have been rarely reported in Korea. Based on the Korea National Cancer Incidence Database, we report the results from survival analysis for cancer patients diagnosed during 1993-2002 and followed up until 31 December 2005 at primary cancer sites. The five-year relative survival rates (RSR) were calculated using the Ederer II method. The Kaplan-Meier method was used to estimate median survival and the 95% confidence intervals. In males, the five-year RSR for all, cancers was 32.5% during 1993-1997 and was 37.8% during 1998-2002. In females, the five-year RSR for all cancers was 53.7% during 19931997 and was 57.0% during 1998-2002. The largest improvement in survival was shown in prostate cancer in males and breast and stomach cancer in females. The median survival durations were 16.3 months in males and 81.6 months in females. This result will be useful for evaluation of cancer treatment outcomes in Korea.